GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Themis Biosyn Ltd (BOM:506879) » Definitions » Gross-Profit-to-Asset %

Gujarat Themis Biosyn (BOM:506879) Gross-Profit-to-Asset % : 49.42% (As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Gujarat Themis Biosyn Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Gujarat Themis Biosyn's annualized Gross Profit for the quarter that ended in Dec. 2024 was ₹1,226 Mil. Gujarat Themis Biosyn's average Total Assets over the quarter that ended in Dec. 2024 was ₹2,482 Mil. Therefore, Gujarat Themis Biosyn's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 49.42%.


Gujarat Themis Biosyn Gross-Profit-to-Asset % Historical Data

The historical data trend for Gujarat Themis Biosyn's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Themis Biosyn Gross-Profit-to-Asset % Chart

Gujarat Themis Biosyn Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 143.56 91.00 88.53 81.26 66.18

Gujarat Themis Biosyn Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.29 57.78 56.15 44.87 49.42

Competitive Comparison of Gujarat Themis Biosyn's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Themis Biosyn's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gujarat Themis Biosyn's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Themis Biosyn's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Gujarat Themis Biosyn's Gross-Profit-to-Asset % falls into.


;
;

Gujarat Themis Biosyn Gross-Profit-to-Asset % Calculation

Gujarat Themis Biosyn's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=1282.006/( (1663.281+2211.133)/ 2 )
=1282.006/1937.207
=66.18 %

Gujarat Themis Biosyn's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=1226.388/( (2481.535+0)/ 1 )
=1226.388/2481.535
=49.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Gujarat Themis Biosyn Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Gujarat Themis Biosyn's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gujarat Themis Biosyn Business Description

Traded in Other Exchanges
Address
S.V Road, Themis House, 11/12 Udyog Nagar, Goregaon (West), Mumbai, MH, IND, 400104
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.

Gujarat Themis Biosyn Headlines

No Headlines